|                      | ** **                                                                                                                                   |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------|
|                      | UNITED STATES  SECURITIES AND EXCHANGE COMMISSION  WASHINGTON, D.C. 20549                                                                    |
|                      |                                                                                                                               |
|                      | **FORM 11-K**                                                                                                                                |
|                      |                                                                                                                               |
|                      | FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE,  SAVINGS  AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF  THE SECURITIES EXCHANGE ACT OF 1934 |
|                      |                                                                                                                               |
| (Mark One)           |
|  X         | ANNUAL REPORT PURSUANT TO  SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934                                                              |
|                      | **   **                                                                                                                       |
|                      | **For the fiscal year ended December 31, 2007**                                                                                              |
|                      | or                                                                                                                            |
|  __   | TRANSITION REPORT PURSUANT  TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934                                                          |
|                      |                                                                                                                               |
|                      | For the transition period from       to                                                              |
|                      |                                                                                                                               |
|                      | Commission file number 1-3619                                                                                                                |
|                      |                                                                                                                               |
| A.                   | Full title of the plan and  the address of the plan, if different from that of the issuer named below:                                       |
|                      | **   **                                                                                                                       |
|                      | **PHARMACIA SAVINGS PLAN  FOR EMPLOYEES RESIDENT IN PUERTO RICO**                                                                            |
|                      | **   **                                                                                                                       |
| B.                   | Name of issuer of the  securities held pursuant to the plan and the address of its principal  executive offices:                             |
|                      |                                                                                                                               |
|                      | **PFIZER INC  235 EAST 42ND STREET  NEW YORK, NEW YORK 10017**                                                                               |

** **

**PHARMACIA SAVINGS PLANFOR EMPLOYEES RESIDENT IN PUERTO RICOINDEX**

| **   **                                                                                                                             |      |
|----------------------------------------------------------------------------------------------------------------------------------------------------|------|
| ** **                                                                                                                                         | Page |
| **FINANCIAL STATEMENTS**                                                                                                                           |      |
| Report of Independent  Registered Public Accounting Firm                                                                                           | 3    |
| Statement of Net Assets Available for Plan Benefits  as of December 31, 2007                                                                  | 4    |
| Statement of Changes in Net Assets Available for  Plan Benefits for the period April 1, 2007 (inception) through  December 31,  2007     | 5    |
| Notes to Financial Statements                                                                                                                      | 6    |
| I    Schedule H, Line 4i - Schedule  of Assets (Held at End of Year) as of December 31, 2007                                   | 13   |
| II   Schedule H, line 4j - Schedule of  Reportable Transactions for the period April 1, 2007 (inception) through  December 31, 2007 | 14   |
| Signature                                                                                                                                          | 15   |
| Exhibit 23.1 - Consent of Independent Registered  Public Accounting Firm                                                                           | 16   |

** **

** REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTINGFIRM**

To the Savings Plan CommitteePharmacia Savings Plan for Employees Resident in Puerto Rico:

We have audited theaccompanying statement of net assets available for plan benefits of thePharmacia Savings Plan for Employees Resident in Puerto Rico (the "Plan")as of December 31, 2007, and the related statement of changes in netassets available for plan benefits for the period April 1, 2007 (inception)through December 31, 2007. These financial statements are the responsibility ofthe Plan's management. Our responsibility is to express an opinion on thesefinancial statements based on our audit.

We conducted our audit inaccordance with the standards of the Public Company Accounting Oversight Board(United States). Those standards require that we plan and perform the audit toobtain reasonable assurance about whether the financial statements are free ofmaterial misstatement. An audit includes examining, on a test basis, evidencesupporting the amounts and disclosures in the financial statements. An auditalso includes assessing the accounting principles used and significantestimates made by management, as well as evaluating the overall financialstatement presentation. We believe that our audit provides a reasonable basisfor our opinion. 

In our opinion, the financialstatements referred to above present fairly, in all material respects, the netassets available for plan benefits of the Plan as of December 31, 2007,and the changes in net assets available for plan benefits for the period April1, 2007 (inception) through December 31, 2007, in conformity with U.S.generally accepted accounting principles.

Our audit was performed forthe purpose of forming an opinion on the basic financial statements taken as awhole. The supplemental Schedule H, Line 4i - Schedule of Assets (Held at Endof Year) as of December 31, 2007 and Schedule H, Line 4j - Schedule ofReportable Transactions for the period April 1, 2007 (inception) throughDecember 31, 2007 are presented for the purpose of additional analysis andare not a required part of the basic financial statements but are supplementaryinformation required by the Department of Labor's Rules and Regulations forReporting and Disclosure under the Employee Retirement Income Security Act of1974 (ERISA). These supplemental schedules are the responsibility of the Plan'smanagement. The supplemental schedules have been subjected to the auditingprocedures applied in the audit of the basic financial statements and, in ouropinion, are fairly stated in all material respects in relation to the basicfinancial statements taken as a whole.

/s/  KPMG  LLP

Memphis, TennesseeJune 25, 2008

**PHARMACIA SAVINGS PLANFOR EMPLOYEES RESIDENT IN PUERTO RICOSTATEMENT OF NET ASSETS AVAILABLE FOR PLAN BENEFITS**

| ** **                                                                                      | ** ** | **December 31,** |
|-------------------------------------------------------------------------------------------------|------------|------------------|
| (in thousands of dollars)                                                                       |            |                  | 2007 |
| **   **                                                                          |            |                  |  |
| **Assets:**                                                                                     |            |                  |  |
| Investments, at fair  value:                                                                    |            |                  |  |
| Pfizer  Inc common stock                                                                        |            | $                | 4,651 |
| Pfizer  Inc preferred stock                                                                     |            |                  | 9,161 |
| Common/collective  trust funds                                                                  |            |                  | 14,789 |
| Mutual  funds                                                                                   |            |                  | 9,141 |
|                                                                                  |            |                  | 37,742 |
| Loans  to participants                                                                          |            |                  | 3,298 |
| Total  investments, at fair value                                                               |            |                  | 41,040 |
|                                                                                  |            |                  |  |
| Receivables:                                                                                    |            |                  |  |
| Company  contributions                                                                          |            |                  | 31 |
| Participant  contributions                                                                      |            |                  | 50 |
| Dividends  and interest                                                                         |            |                  | 6 |
| Total  receivables                                                                              |            |                  | 87 |
|                                                                                  |            |                  |  |
| Total  assets                                                                                   |            |                  | 41,127 |
|                                                                                  |            |                  |  |
| **Liabilities:**                                                                                |            |                  |  |
| Payable for securities  purchased                                                               |            |                  | (46) |
| Total  liabilities                                                                              |            |                  | (46) |
|                                                                                  |            |                  |  |
| **Net assets available  for plan benefits, at fair value**                                      |            |                  | 41,081 |
|                                                                                  |            |                  |  |
| Adjustment from fair value  to contract value for fully benefit-responsive investment contracts |            |                  | (62) |
|                                                                                  |            |                  |  |
| **Net assets available  for plan benefits**                                                     |            | $                | 41,019 |

See Notes to Financial Statements which are anintegral part of these financial statements.

**PHARMACIA SAVINGS PLANFOR EMPLOYEES RESIDENT IN PUERTO RICOSTATEMENT OF CHANGES IN NET ASSETS AVAILABLE FOR PLAN BENEFITS**

|                                                      | **Period April 1, 2007 (inception) through** |
|------------------------------------------------------|----------------------------------------------|
| (in thousands of dollars)                            | **December 31, 2007**                        |
| **   **                               |                                              |  |
| **Additions/(reductions):**                          |                                              |  |
| Additions/(reductions)  to net assets attributed to: |                                              |  |
| Investment  income/(loss):                           |                                              |  |
| Net  depreciation in investments                     | $                                            |  (566) |
| Interest  income                                     |                                              | 469  |
| Dividend  income                                     |                                              | 577  |
| Interest  income on loans to participants            |                                              | 205  |
|                                                      |                                              | 685  |
|                                       |                                              |  |
| Transfers  into Plan                                 |                                              | 40,742  |
|                                                      |                                              |  |
| Contributions:                                       |                                              |  |
| Participant                                          |                                              | 1,944  |
| Company                                              |                                              | 1,144  |
|                                                      |                                              | 3,088  |
|                                       |                                              |  |
| Total  additions                                     |                                              | 44,515  |
|                                       |                                              |  |
| **Deductions:**                                      |                                              |  |
| Deductions  from net assets attributed to:           |                                              |  |
| Benefits  paid to participants                       |                                              | (3,496) |
| Total  deductions                                    |                                              | (3,496) |
|                                       |                                              |  |
| Net  increase                                        |                                              | 41,019  |
|                                       |                                              |  |
| **Net assets available  for plan benefits:**         |                                              |  |
| Inception,  April 1, 2007                            |                                              | --  |
| December  31, 2007                                   | $                                            |  41,019  |

See Notes to Financial Statements which are an integralpart of these financial statements. 

**PHARMACIA SAVINGS PLANFOR EMPLOYEES RESIDENT IN PUERTO RICONotes to Financial StatementsDecember 31, 2007**

**1.    Descriptionof the Plan**

ThePharmacia Savings Plan for Employees Resident in Puerto Rico (Plan) became effectiveon April 1, 2007, and is available to certain eligible employees and formeremployees of Pfizer Pharmaceuticals, LLC who legally reside in PuertoRico.  Participants in the Plan were formerly part of the PharmaciaSavings Plan, a defined contribution retirement plan sponsored by Pfizer Inc. The Plan generally mirrors the provisions of the Pharmacia Savings Plan;however, it is not a tax-qualified plan under the Internal Revenue Code of1986, as amended (U.S. Code).  The Plan is subject to the provisions ofthe Employee Retirement Income Security Act of 1974, as amended, (ERISA) andthe Puerto Rico Internal Revenue Code of 1994, as amended (Puerto Rico Code). Effective April 1, 2007, a Puerto Rico-based trust, the Pharmacia Savings Planfor Residents of Puerto Rico, was also created to hold the assets of the Plan. Banco Popular de Puerto Rico is the trustee.  The Northern Trust Company(Northern Trust) is custodian of the Plan's assets.  Effective April 1,2007, the assets and liabilities of the affected employees in the PharmaciaSavings Plan and trust were transferred to the new plan and trust.  PfizerPharmaceuticals LLC (the Company or Plan Sponsor), a subsidiary of Pfizer Inc, isthe sponsor of the Plan.

Underthe Puerto Rico Code, any qualified plan involving pre-tax contributions ofcash or deferred arrangements must comply with one of two nondiscriminationtests.  For the period ended December 31, 2007, the Plan complied withboth tests.

Thefollowing is a general description of certain provisions of the Plan.Participants should refer to the Plan document for  more completeinformation.

***PlanAdministration***The Savings Plan Committee ofPfizer Inc monitors and reports on the selection and termination of the trusteeand investment managers and on the investment activity and performance of thePlan.

***AdministrativeExpenses***Administrative expenses and outsideservice provider expenses (e.g., investment manager, recordkeeping and trusteefees) incurred in the operation of the Plan are paid by Pfizer Inc.

***Contributions***Participants may elect to contribute from 1% to 10% ona before-tax basis and/or 1% to 10% on an after-tax basis, in whole percentages,of their Regular Earnings, as defined in the Plan document; provided, however,that a participant's total after-tax and before-tax contributions may notexceed 15% of the participant's Regular Earnings.  Before-tax contributionsare subject to certain restrictions under the Puerto Rico Code.  Contributionsof up to 5% of compensation are matched 100% by the Company.  Participants'contributions in excess of 5% are not matched.  Participants who areeligible employees are permitted to roll over into the Plan eligibledistributions from other plans that are qualified under Section 1165(a) of thePuerto Rico Code.

***Participant Accounts***Eachparticipant's account is credited with the participant's contributions,allocations of the Company's contribution, Plan earnings and administrativeexpenses. Allocations are based on participant earnings or account balances, asdefined. Participants are immediately vested in the full value of their account(i.e., participant's and Company's contributions).

***InvestmentOptions***NonparticipantDirected Funds *--*

| Pfizer Common Stock (ESOP)  Fund | -- | This  fund invests Company contributions in the common stock of Pfizer Inc.                                                                                                                                                                                                                                             |
|----------------------------------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                  |    |                                                                                                                                                                                                                                                                                                                         |
| Pfizer Preferred Stock Fund      | -- | This  fund holds investments in the preferred stock of Pfizer Inc which were  allocated to participants before the spin-off of Puerto Rico participants  from the Pharmacia Savings Plan. Dividends paid to the participants' Pfizer  Preferred Stock Fund accounts are substituted for an allocation in common  stock. |

Participantsmay diversify all or a portion of their Company matching contributions into anyof the available investment funds at any time after the contributions have beenmade to their account.

ParticipantDirected Funds -- Each participant in the Plan elects to have his or hercontributions invested in any one or combination of the following investmentfunds:

| a) | Income Fund                                                                                                          |
|----|----------------------------------------------------------------------------------------------------------------------|
| b) | American Balanced Fund                                                                                               |
| c) | Neuberger & Berman Guardian Equity Fund                                                                          |
| d) | Fidelity Growth Company Fund                                                                                         |
| e) | Templeton Funds Inc Foreign Fund                                                                                     |
| f) | Pfizer Common Stock Fund                                                                                             |
| g) | T. Rowe Price Stable Value Fund                                                                                      |
| h) | Barclays Global Investors Equity Index Fund                                                                          |
| i) | Any combination of the above, provided that a minimum of 5% and a  multiple of 1% is directed to each fund selected. |

Participantsmay elect to transfer or allocate their participant contribution balances andearnings thereon to any of the above funds.

Thetrustee of the Plan, Banco Popular de Puerto Rico, and the custodian, NorthernTrust, also manage investments in its sponsored funds and therefore, each isdeemed to be a party-in-interest and a related party.

***Eligibility***Allemployees of the Company who are employed within the Commonwealth of PuertoRico, except certain employees who are either covered by a collectivebargaining agreement and have not negotiated to participate in the Plan or areemployed by a unit not designated for participation in the Plan, are eligibleto enroll in the Plan on their date of hire.

***Loansto Participants***ThePlan has a loan provision which allows participants to borrow from their fundaccounts a minimum of five hundred dollars or three thousand dollars for aprimary residence loan up to a maximum equal to the lesser of 50% of theirvested account balance or fifty thousand dollars (reduced by the highestoutstanding loan balance within the previous twelve months). Certain Company matchingcontributions and earnings thereon are not available for loans.  Loanterms range from 1-5 years or up to 10 years for the purchase of a primaryresidence.  The loans are secured by the balance in the participant'saccount and bear interest at a rate that is equal to the prime rate, asdefined, at the beginning of the quarter in which the loan originates, plus 1%.Interest rates on outstanding loans ranged from 5% to 10.5% at December 31, 2007.Interest paid is credited to the account of the participant. Repayments may notnecessarily be made to the same fund from which amounts were borrowed.Repayments are credited to the applicable funds based on the participant'sinvestment elections at the time of repayment.  In the event oftermination, participants will have 90 days to repay the loan before the loanis considered taxable to the participant. 

***BenefitPayments***Benefitsare paid either in cash or a combination of cash and common stock. Common stockis issued only with respect to the participant's accounts in the Pfizer CommonStock Fund, the Pfizer Common Stock (ESOP) Fund and the Pfizer Preferred Stock Fund.Upon retirement or death, the full value of the participant's accounts is paidin either a lump sum or in installments.

***In-ServiceWithdrawals***Participantsmay also elect to make in-service or hardship withdrawals from their accountbalances subject to the provisions of the Plan.

***PlanTermination***ThePlan Sponsor and Pfizer Inc (Parent) expect to continue the Plan indefinitely,but reserve the right to amend, suspend or discontinue it in whole or in partat any time by action of the Plan Sponsor's Managers or the Board of Directorsof the Parent or the authorized designee(s) of either of them. In the event oftermination of the Plan, each participant shall be entitled to the full valueof his or her account balance as though she had retired as of the date of suchtermination. No part of the invested assets established pursuant to the Planwill at any time revert to the Company except as otherwise permitted underERISA.

**2.    Summaryof Significant Accounting Policies**

***Basisof Accounting***Thefinancial statements of the Plan have been prepared on the accrual basis ofaccounting, however, benefit payments are recorded when paid. For treatment ofbenefits payable, refer to Note 8.

Asdescribed in Financial Accounting Standards Board Staff Position, FSP AAG INV-1and SOP 94-4-1, *Reporting of Fully Benefit-Responsive Investment ContractsHeld by Certain Investment Companies Subject to the AICPA Investment CompanyGuide and Defined-Contribution Health and Welfare and Pension Plans* (theFSP), investment contracts held by a defined-contribution plan are required tobe reported at fair value.  However, contract value is the relevantmeasurement attribute for that portion of the net assets available for benefitsof a defined-contribution plan attributable to fully benefit-responsiveinvestment contracts because contract value is the amount participants wouldreceive if they were to initiate permitted transactions under the terms of theplan.  As required by the FSP, the accompanying statement of net assetsavailable for plan benefits presents the fair value of the investment contractsas well as the adjustment of the fully benefit-responsive investment contractsfrom fair value to contract value.  The statement of changes in net assetsavailable for plan benefits is prepared on a contract value basis.

***Useof Estimates***Thepreparation of financial statements in conformity with U.S. generally acceptedaccounting principles requires management to make estimates and assumptionsthat affect the reported amounts of assets and liabilities at the date of thefinancial statements, the reported amount of increase or decrease to net assetsduring the reporting period, and disclosure of contingent assets andliabilities. Actual results could differ from those estimates.

***InvestmentValuation***Pfizer Inc common stock is valued at the closingmarket price on the last business day of the year. Common/collective trust funds,except for the investment in the T. Rowe Price Stable Value Fund, are stated atredemption value as determined by the trustees of such funds based upon theunderlying securities stated at fair value. The T. Rowe Price Stable Value Fundrepresents a common/collective trust fund with an underlying investment inguaranteed investment contracts (GICs), which are reported at fair value, withan appropriate adjustment to report such contracts at contract value, by theinsurance companies and underlying banks, respectively, because theseinvestments are fully benefit responsive. Mutual funds are recorded at fairvalue based on the closing market prices obtained from national exchanges ofthe underlying investments of the respective fund as of the last business dayof the year. Investments in money market instruments are generally short-termand are valued at cost, which approximates market.  Loans to participants,which are subject to various interest rates, are recorded at cost whichapproximates fair value. 

Pfizer preferred stockprovides dividends at the annual rate of 6.25% and is convertible at the holder'soption into 2.57487 shares of Pfizer common stock.  It may also beredeemed by Pfizer Inc at a per share equivalent stated value of $40.30.  Pfizerpreferred stock is valued using the higher of the per-share equivalent statedvalue of $40.30 or the quoted market price of Pfizer Inc common stockmultiplied by 2.57486 on the last business day of the Plan year (preferredstock share balances maintained by the Plan's trustee and recordkeeper are on abasis equal to a multiple of 1,000 of the share balance and one-thousandth ofthe $40,300 stated value). Pfizer preferred stock was valued at $58.53 atDecember 31, 2007 based on the closing Pfizer Inc common stock price of $22.73on December 31, 2007.

***Risksand Uncertainties***Investment securities,including Pfizer Inc common and preferred stock, are exposed to various risks,such as interest rate, market and credit risk. Due to the level of riskassociated with certain investment securities, it is possible that changes intheir fair values could occur in the near term and such changes couldmaterially affect participants' account balances and the amounts reported inthe statements of net assets available for plan benefits.

***InvestmentTransactions***Purchases and sales ofsecurities are reflected on a trade-date basis. Dividend income is recorded onthe ex-dividend date. Interest income is recorded as earned.

***Net Appreciation/(Depreciation) in Fair Value ofInvestments***The Plan presents in the statements of changes in netassets available for plan benefits the net appreciation/(depreciation) in thevalue of its investments which consists of the realized gains and losses andthe unrealized gains and losses on those investments, and the change incontract value of the common/collective trust funds holding investments inGICs.  Realized gains and losses on sales of investments represent thedifference between the net proceeds and the cost of the investments (averagecost if less than the entire investment is sold).  Unrealized gains andlosses on investments represent the difference between the cost of theinvestments and their fair value at the end of the year.

***Recently Issued Accounting Standards Not Adopted as ofDecember 31, 2007***In September 2006, the FinancialAccounting Standards Board (FASB) issued Statement of Financial AccountingStandard No. 157,*Fair Value Measurements* (SFAS 157) and inFebruary 2008, issued Financial Staff Position No. 157-2, *Effective Date ofFASB Statement No.157*. Those provisions relate to our financial assets andliabilities carried at fair value and our fair value disclosures related tofinancial assets and liabilities.  SFAS 157 defines fair value, expands relateddisclosure requirements and specifies a hierarchy of valuation techniques basedon the nature of the inputs used to develop the fair value measures. Theprovisions of SFAS 157 are effective for the Plan on January 1, 2008. Theadoption of SFAS 157 is not expected to have a material impact on net assetsavailable for plan benefits.

**3.    TaxStatus of the Plan**

An application has been filed with the Puerto RicoDepartment of Treasury to determine whether the Plan and related trust aredesigned in accordance with the applicable sections of the Puerto Rico Code. Theplan administrator and the Plan's tax counsel believe that the Plan iscurrently designed and being operated in compliance with all of the applicablerequirements of the Puerto Rico Code. Accordingly, no provision has been madefor Puerto Rico income taxes in the accompanying financial statements.

Contributions made to the Plan by the Company,including pre-tax contributions made on the participants' behalf and anyappreciation on all funds in the participants' accounts, are not taxable to theparticipants under current Puerto Rico income tax law while these amountsremain the Plan and the Plan maintains its qualified status.

**4.    Investments**

The followinginvestments represent 5% or more of the Plan's net assets available for planbenefits.

| ** **                                         | ** ** | **December 31,** |
|----------------------------------------------------|------------|------------------|
| (in thousands of dollars)                          | ** ** | **2007**         |
| **   **                             |            |                  |  |
| T. Rowe Price Stable Value Fund, at contract value |            | $                | 10,440 |
| Pfizer Inc preferred stock (156,524 shares)        |            |                  | 9,161 |
| Pfizer Inc common stock (204,639 shares)           |            |                  | 4,651 |
| Barclays Global Investors Equity Index Fund        |            |                  | 4,043 |
| Fidelity Growth Company Fund                       |            |                  | 2,688 |
| Neuberger & Berman Guardian Equity Fund        |            |                  | 2,559 |
| Templeton Funds Inc Foreign Fund                   |            |                  | 2,189 |
|                                                    |            |                  |  |

   

**5.    NetDepreciation in Investments**

ThePlan's investments (including gains and losses on investments sold, as well asheld during the year) appreciated/(depreciated) in value as follows:

|                                | ** ** | **April 1, 2007 (inception) through** |
|--------------------------------|------------|---------------------------------------|
| (in thousands of dollars)      | ** ** | **December 31, 2007**            |
|                 |            |                                       |  |
| Mutual funds                   |            | $                                     | 788  |
| Pfizer Inc common stock        |            |                                       | (557) |
| Pfizer Inc preferred stock     |            |                                       | (1,020) |
| Common/collective trust  funds |            |                                       | 223  |
|                                |            | $                                     | (566) |

** 6.    InvestmentContracts with Insurance Companies**

TheT. Rowe Price Stable Value Fund consists primarily of fully benefit-responsiveGICs.  The contract value of the GICs represents contributions made underthe contract and related earnings offset by participant withdrawals. 

**7.    Nonparticipant-DirectedInvestments**

Information about the netassets and significant components of the changes in net assets relating to thenonparticipant-directed investments is as follows:

| ** **                                  | **December 31,** |
|---------------------------------------------|------------------|
| (in thousands of dollars)                   |                  | **2007** |
|                              |                  |  |
| **Assets:**                                 |                  |  |
| Investments, at fair value:                 |                  |  |
| Common/collective trust funds               | $                | 99 |
| Pfizer Inc common stock                     |                  | 2,323 |
| Pfizer Inc preferred stock                  |                  | 9,161 |
| Total  investments                          |                  | 11,583 |
|                              |                  |  |
| Receivables:                                |                  |  |
| Company  contributions                      | *** ***     | 31 |
| Total  receivables                          | *** ***     | 31 |
| Total  assets                               |                  | 11,614 |
|                              |                  |  |
| **Liabilities:**                            |                  |  |
| Payable  for securities purchased           |                  | (11) |
| Total  liabilities                          |                  | (11) |
|                              |                  |  |
| **Net assets available for  plan benefits** | $           | 11,603 |

**   **

| ** **                                          | **April 1, 2007 (inception) through** |
|-----------------------------------------------------|---------------------------------------|
| (in thousands of dollars)                           | **December 31, 2007**                 |
|                                      |                                       |  |
| **Change in net assets:**                           |                                       |  |
| Investment  income/(loss):                          |                                       |  |
| Net depreciation in investments                     | $                                     | (1,277) |
| Dividends                                           |                                       | 398  |
| Total  investment loss                              |                                       | (879) |
|                                      |                                       |  |
| Contributions  and other:                           |                                       |  |
| Company  contributions                              |                                       | 1,147  |
| Benefits  paid to participants                      |                                       | (903) |
| Loan  transaction transfers, net                    |                                       | (36) |
| Transfers  to participant-directed investments, net |                                       | (1,181) |
| Transfers  into Plan                                |                                       | 13,455  |
|                                                     |                                       |  |
|                                                |                                  |   |
| Net  increase                                       |                                       | 11,603  |
| Net assets available for  plan benefits:            |                                       |  |
| Inception,  April 1, 2007                           |                                       | --  |
| December  31, 2007                                  | $                                     | 11,603  |

**8.    Reconciliationof Financial Statements to Form 5500**

Amounts allocated towithdrawing participants are recorded as benefits paid on Form 5500 for benefitclaims that have been processed and approved for payment prior to December 31but not yet paid as of that date.  Deemed distributions, representingwithdrawing participants with outstanding loan balances for which nopost-default payment activity has occurred, are not reported on Form 5500 innet assets available for plan benefits.  Also, investments in the T. RowePrice Stable Value Fund are reported on Form 5500 at fair value, whereas the netassets available for plan benefits in the financial statements report suchinvestments at contract value.

The following is areconciliation of net assets available for plan benefits according to thefinancial statements to the Plan's Form 5500 expected to be filed for 2007.

| ** **                                                                | ** ** | **December 31,** |
|---------------------------------------------------------------------------|------------|------------------|
| (in thousands of dollars)                                                 | ** ** | ** **       | **2007 ** |
| **   **                                                    |            |                  |  |
| Net assets available for plan benefits per the  financial statements      |            | $                | 41,019  |
| Adjustment of fixed income  investments from contract value to fair value |            |                  | 62  |
| Amounts allocated to  withdrawing participants                            |            |                  | (7) |
| Deemed distributions                                                      |            |                  | (92) |
| Net assets available for  plan benefits per Form 5500                     |            | $                | 40,982  |

 

The following is a reconciliation of benefitspaid to participants according to the financial statements to Form 5500:

|                                                                                        | **April 1, 2007 (inception) through** |
|----------------------------------------------------------------------------------------|---------------------------------------|
| (in thousands of dollars)                                                              | **December 31, 2007**                 |
|                                                                         |                                       |  |
| Benefits paid to  participants per the financial statements                            | $                                     | 3,496 |
| Amounts allocated to withdrawing participants and  deemed distributions at end of year |                                       | 99 |
| Benefits paid to  participants per Form 5500                                           | $                                     | 3,595 |

Thefollowing is a reconciliation of net depreciation in investments per thefinancial statements to the Form 5500:

|                                                                                                | **April 1, 2007 (inception) through** |
|------------------------------------------------------------------------------------------------|---------------------------------------|
| (in thousands of dollars)                                                                      | **December 31, 2007**                 |
|                                                                                      |                                       |  |
| Net depreciation in investments per the financial  statements                                  | $                                     | (566) |
| Adjustment of fixed income investments from contract  value to fair value at December 31, 2007 |                                       | 62   |
| Net depreciation in investments per the  Form 5500                                        | $                                     | (504) |

** **

**Schedule I**

**PHARMACIA SAVINGS PLANFOR EMPLOYEES RESIDENT IN PUERTO RICOSCHEDULE H, Line 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)December 31, 2007(in thousands of dollars)**

| ** **                                        | **Interest  Rate** | **Maturity  Date**          | **Number of  Shares or  Units** | **  ** | **Cost**   | **Fair  Value** |
|---------------------------------------------------|--------------------|-----------------------------|---------------------------------|------------------|------------|-----------------|
|                                    |                    |                             |                                 |                  |            |                 |
| Corporate Stock - Preferred:                      |                    |                             |                                 |                  |            |                 |
| *Pfizer Inc                                       |                    |                             | 156,524                         |                  | $ 6,310    | $ 9,161         |
| Corporate Stock - Common:  * Pfizer Inc           |                    |                             | 204,639                         |                  | 5,043      | 4,651           |
| Common/collective trust funds:               |                    |                             |                                 |                  |            |                 |
| T. Rowe Price Stable Value Common Trust Fund      |                    |                             | 10,440,081                      |                  | 10,440     | 10,502          |
| MFO BGI Equity Index Fund T                       |                    |                             | 87,022                          |                  | 3,970      | 4,043           |
| *NTGI Collective Short-Term Investment Fund       |                    |                             | 243,349                         |                  | 244        | 244             |
| Total  common/collective trust funds****          |                    |                             |                                 |                  | $14,654    | $14,789         |
|                                              |               |                        |                            |             |       |            |
|                                                   |                    |                             |                                 |                  |            |                 |
| Registered  Investment Companies:                 |                    |                             |                                 |        |            |                 |
| MFO Fidelity Growth Company Fund                  |                    |                             | 32,393                          |                  | 2,498      | 2,688           |
| MFO Neuberger & Berman Guardian Equity Fund   |                    |                             | 143,043                         |                  | 2,775      | 2,559           |
| MFO Templeton Funds Inc Foreign Fund Class A |                    |                             | 174,854                         |                  | 2,483      | 2,189           |
| MFO American Balanced Fund Inc                    |                    |                             | 88,298                          |                  | 1,697      | 1,705           |
| Total Registered Investment Companies             | ** **         | ** **                  | ** **                      |                  | $9,453     | $9,141          |
| **   **                            | ** **         | ** **                  | ** **                      | ** **       | ** ** | ** **      |
| **Loans to Participants (784 loans)**             | 5.0% to  10.5%     | January 2008  to April 2017 | ** **                      |                  |            | $3,298          |
|                                                   |                    |                             |                                 |                  |            |                 |
| **Total**                                         | ** **         | ** **                  | ** **                      | ** **       |            | **$41,040**     |

* Party-in-interest asdefined by ERISA.

See accompanying report of independent registered publicaccounting firm.

**Schedule II**

**PHARMACIA SAVINGS PLANFOR EMPLOYEES RESIDENT IN PUERTO RICOSCHEDULE H, 4j - SCHEDULE OF REPORTABLE TRANSACTIONSFor the period April 1, 2007 (Inception) through December 31, 2007(in thousands of dollars)**

| **(a)  Identity of  party involved** | ** ** | **(b)  Description  of asset**   | ** ** | **(c)  Purchase  price** | ** ** | **(d)  Selling  price** | ** ** | **(g)  Cost  of asset** | ** ** | **(h)  Current  value of  asset on  transaction  date** | ** ** | **(i)  Net gain/  (loss)** |
|--------------------------------------|------------|----------------------------------|------------|--------------------------|------------|-------------------------|------------|-------------------------|------------|---------------------------------------------------------|------------|----------------------------|
|                       |            |                                  |            |                          |            |                         |            |                         |            |                                                         |            |                            |
| Pfizer Inc*                          |            | Common stock; 150 purchases | $          | 14,470                   | $          | --                      | $          | 14,470                  | $          | 14,470                                                  | $          | --                         |
| Pfizer Inc*                          |            | Common stock; 128 sales     | $          | --                       | $          | 13,079                  | $          | 13,403                  | $          | 13,079                                                  | $          | (324)                      |
| Pfizer Inc*                          |            | Preferred stock; 121 sales  | $          | 1,090                    | $          | 1,758                   | $          | 1,090                   | $          | 1,758                                                   | $          | 668                        |
|                                      |            |                                  |            |                          |            |                         |            |                         |            |                                                         |            |                            |
|                       |            |                                  |            |                          |            |                         |            |                         |            |                                                         |            |                            |

*Party-in-interestas defined by ERISA

See accompanying report of independent registered publicaccounting firm.

**SIGNATURE**

Pursuant to the requirementsof the Securities Exchange Act of 1934, the members of the Savings PlanCommittee have duly caused this annual report to be signed on its behalf by theundersigned thereunto duly authorized.

| PHARMACIA SAVINGS PLAN FOR  EMPLOYEES RESIDENT IN PUERTO RICO                                                                         |
|---------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                        |
| By:  /s/ Richard  A.  Passov                |
|                                                                                                                        |
|                                                                                                                        |
|                                                                                                                        |
| Richard A. Passov*Chair, Savings Plan Committee*                                                                                      |

Date:  June 25,2008

**Exhibit23.1**

** **

**CONSENTOF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

** **

To the Savings Plan CommitteePharmacia Savings Plan for Employees Resident in Puerto Rico: 

We consent to incorporation by reference inthe Registration Statement on Form S-8 dated March 1, 2007 (FileNo. 333-140987) of our report dated June 25, 2008, relating to thestatement of net assets available for plan benefits of the Pharmacia SavingsPlan for Employees Resident in Puerto Rico as of December 31, 2007, andthe related statement of changes in net assets available for plan benefits for theyear then ended, and the related supplemental Schedule H,Line 4i - Schedule of Assets (Held at End of Year) as ofDecember 31, 2007 and Schedule H, Line 4j - Scheduleof Reportable Transactions for the Year Ended December 31, 2007, whichreport appears in the December 31, 2007 annual report on Form 11-K ofthe Pharmacia Savings Plan for Employees Resident in Puerto Rico. 

/s/KPMG LLP                                          

Memphis, TennesseeJune 25, 2008